Search Results - "Padella, A"

SETD2 and histone H3 lysine 36 methylation deficiency in advanced systemic mastocytosis by Martinelli, G, Mancini, M, De Benedittis, C, Rondoni, M, Papayannidis, C, Manfrini, M, Meggendorfer, M, Calogero, R, Guadagnuolo, V, Fontana, M C, Bavaro, L, Padella, A, Zago, E, Pagano, L, Zanotti, R, Scaffidi, L, Specchia, G, Albano, F, Merante, S, Elena, C, Savini, P, Gangemi, D, Tosi, P, Ciceri, F, Poletti, G, Riccioni, L, Morigi, F, Delledonne, M, Haferlach, T, Cavo, M, Valent, P, Soverini, S

“…The molecular basis of advanced systemic mastocytosis (SM) is not fully understood and despite novel therapies the prognosis remains dismal. Exome sequencing…”
Get full text

Fanconi anemia gene variants in therapy-related myeloid neoplasms by Voso, M T, Fabiani, E, Zang, Z, Fianchi, L, Falconi, G, Padella, A, Martini, M, Li Zhang, S, Santangelo, R, Larocca, L M, Criscuolo, M, La Brocca, A, Cutcutache, I, Rozen, S, Simonetti, G, Manfrini, M, Martinelli, G, Hohaus, S, Leone, G, Tan, P, Tenen, D G

Get full text

Chromothripsis in acute myeloid leukemia: Biological features and impact on survival by Fontana, M C, Marconi, G, Feenstra, J D M, Fonzi, E, Papayannidis, C, di Rorá, A G L, Padella, A, Solli, V, Franchini, E, Ottaviani, E, Ferrari, A, Baldazzi, C, Testoni, N, Iacobucci, I, Soverini, S, Haferlach, T, Guadagnuolo, V, Semerad, L, Doubek, M, Steurer, M, Racil, Z, Paolini, S, Manfrini, M, Cavo, M, Simonetti, G, Kralovics, R, Martinelli, G

“…Chromothripsis is a one-step genome-shattering catastrophe resulting from disruption of one or few chromosomes in multiple fragments and consequent random…”
Get full text

PF169 LONG‐TERM INHIBITION OF CHK1/CHK2 KINASES MODIFY ACUTE LYMPHOBLASTIC LEUKEMIA CELL LINE RESPONSE TO DNA DAMAGING AGENTS by Ghelli Luserna Di Rora’, A., Bocconcelli, M., Padella, A., Fontana, M.C., Ferrari, A., Imbrogno, E., Baldazzi, C., Testoni, N., Simonetti, G., Martinelli, G.

“…Background: Acute lymphoblastic leukemia (ALL) cells respond to chemotherapy, or more generally to DNA damages, by activating different DNA Damage Response…”
Get full text

PS1020 SNP ARRAY REVEALS A NEW DELETION OF JAK2 IN AML PATIENTS by Cerchione, C., Guadagnuolo, V., Papayannidis, C., Fontana, M.C., Padella, A., Iacobucci, I., Simonetti, G., Marconi, G., Paolini, S., Abbenante, M., Parisi, S., Volpato, F., Ottaviani, E., Delledonne, M., Biasco, G., Martinelli, G.

“…Background: Acute Myeloid Leukemia (AML) is a disease of the elderly that initiates in a hematopoietic stem cell and is characterized by clonal hematopoiesis…”
Get full text

PS976 METABOLIC REPROGRAMMING OF ACUTE MYELOID LEUKEMIA STEM‐ PROGENITOR CELLS AT RELAPSE by Ghetti, M., Padella, A., Pazzaglia, M., De Tommaso, R., Fontana, M., Bruno, S., Bochicchio, M.T., Ferrari, A., Napolitano, R., Franchini, E., Nanni, J., Marconi, G., Papayannidis, C., Remondini, D., Martinelli, G., Simonetti, G.

“…Background: Primary chemo‐refractory disease and relapse are the most important causes of mortality in acute myeloid leukemia (AML) patients (Döhner et al., N…”
Get full text

PS931 ADULT TRIPLE NEGATIVE ACUTE LYMPHOBLASTIC LEUKEMIA FUSION DETECTION: CHALLENGING AIM FOR PH‐ ALTERNATIVE THERAPIES by Ferrari, A., Vitali, S., Baldazzi, C., Ferrari, G., Robustelli, V., Luserna Di Rora, A. Ghelli, Fonzi, E., Tebaldi, M., Salvi, S., Papayannidis, C., Paolini, S., Padella, A., Bochicchio, M., Marconi, G., Imbrogno, E., Pasquini, G., Santoro, A., Hernández‐Rivas, J., Calistri, D., Castellani, G., Testoni, N., Remondini, D., Martinelli, G.

“…Background: The adult “triple negative” [Ph‐/‐/‐; neg for t(9;22); t(1;19); t(4;11); 61% of adult B‐ALL (Roberts KG et al., J Clin Oncol. 2017)] B‐ALL group is…”
Get full text

PS928 “3C‐UP” A NEW ADULT PHILADELPHIA NEGATIVE ACUTE LYMPHOBLASTIC LEUKEMIA SUBGROUP: NOVEL MOLECULAR MARKERS by Ferrari, A., Vitali, S., Robustelli, V., Luserna di Rorà, A. Ghelli, Baldazzi, C., Righi, S., Fonzi, E., De Matteis, S., Ghetti, M., Napolitano, R., Tebaldi, M., Salvi, S., Papayannidis, C., Marconi, G., Paolini, S., Ferrari, G., Fontana, M., Imbrogno, E., Padella, A., Simonetti, G., Pasquini, G., Santoro, A., Hernández‐Rivas, J., Calistri, D., Castellani, G., Sabattini, E., Testoni, N., Remondini, D., Martinelli, G.

“…Background: The adult “triple negative” [Ph‐/‐/‐; neg for t(9;22); t(1;19); t(4;11); 61% of adult B‐ALL (Roberts KG et al., JCO. 2017)] B‐ALL group is…”
Get full text

PS997 A NEW BIOMARKER OF RESPONSE TO 5‐AZACITIDINE THERAPY IN MDS AND AML PATIENTS: SIRPB1 by Cerchione, C., Guadagnuolo, V., Papayannidis, C., Iacobucci, I., Padella, A., Simonetti, G., Paolini, S., Abbenante, M., Parisi, S., Volpato, F., Fontana, M.C., Ottaviani, E., Testoni, N., Baldazzi, C., Delledonne, M., Filì, C., Malagola, M., Cattina, F., Bernardi, S., Russo, D., Martinelli, G.

“…Background: Myelodisplastic syndromes (MDS) and Acute Myeloid Leukemia (AML) are a group of diseases of the elderly that initiates in a hematopoietic stem cell…”
Get full text

PF197 A NEW CLASSIFICATION OF ACUTE MYELOID LEUKEMIA BASED ON INTEGRATED GENOMICS AND METABOLOMICS by Simonetti, G., Padella, A., Mengucci, C., Fonzi, E., Picone, G., Pazzaglia, M., Perricone, M., Fontana, M., Bruno, S., Bochicchio, M.T., Franchini, E., Nanni, J., Marconi, G., Valle, I.F., De Tommaso, R., Ferrari, A., Ghetti, M., Napolitano, R., Papayannidis, C., Ghelli Luseran di Rorà, A., Cerchione, C., Ottaviani, E., Castellani, G., Remondini, D., Capozzi, F., Martinelli, G.

“…Background: An expanding body of evidence indicates that targeting cell metabolism is a promising therapeutic strategy in acute myeloid leukemia (AML)…”
Get full text